Systematic review, meta-analysis and economic modelling of ...

Appendix 923. Westwood ME, Whiting PF, Kleijen J. How does study quality affect the results of a diagnostic metaanalysis?BMC Med Res Methodol 2005;5(1):20.24. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnosticaccuracy studies. BMC Med Res Methodol. 2005;5:19.25. Whiting P, Rutjes AW, Dinnes J, Reitsma JB, Bossuyt PM, Kleijnen J. A systematic review findsthat diagnostic reviews fail to incorporate quality despite available tools. J Clin Epidemiol2005;58(1):1–12.26. Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J. Development and validation ofmethods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004;8(25).27. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards completeand accurate reporting of studies of diagnostic accuracy: The STARD initiative, 2003. Departmentof Clinical Epidemiology and Biostatistics Academic Medical Centre, University of Amsterdam, TheNetherlands.28. Lijmer JG, Mol JJ, Heisterkamp S, Bonsel GJ, van der Meulen JHP, Bossuyt PMM. Empirical evidenceof design-related bias in studies of diagnostic tests. JAMA 1999;282:1061–6.29. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. In Egger M, DaveySmith G, Altman DG (editors). Systematic reviews in health care: meta-analysis in context. 2nd edn.London: BMJ Publishing Group; 2001.30. Harbord RM, Deeks JJ, Egger M, et al. A unification of models for meta-analysis of diagnosticaccuracy studies. Biostatistics 2007; 8:239–51.31. Sutton AJ, Cooper NJ, Goodacre S, Stevenson M. Integration of meta-analysis and economicdecision modelling for evaluating diagnostic tests. Med Decis Making 2008;28:650–67.32. Oluboyede Y, Goodacre S, Wailoo AJ on behalf of the ESCAPE Research Team. Cost-effectiveness ofchest pain unit care in the NHS. BMC Health Serv Res 2008;8:174.33. Wailoo AJ, Goodacre S, Sampson F, et al. Primary angioplasty versus thrombolysis for acuteST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty Project.Heart 2009; published online, doi:10.1136/hrt.2009.167130.34. National Institute for Clinical Excellence. Guide to the methods of technology appraisals. 2008. URL:http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf35. Stinnett, A., Mullahy, J., 1998. Net health benefits: a new framework for the analysis of uncertaintyin cost-effectiveness analyses. Med Dec Making 18:S68–80.36. Claxton K, Sculpher M, McCabe C, Briggs AH, Akehurst R, Buxton M, Brazier J, O’Hagan T.Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. HealthEconomics 2005;14(4):339–47.37. Inglehart DL. Simulating stable stochastic systems, V: comparison of ratio estimators. Naval ResLogist Quart 1975;22:553–65.38. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectivenessacceptability curves. Health Econ 10:779–87.39. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting.Health Econ 1996;5:513–24.40. Ades AE, Lu G, Claxton K. Expected values of sample information calculation in medical decisionmaking. Med Decis Making 2004;24:207–27.41. Goodacre S, Sampson F, Stevenson M, Wailoo A, Sutton AJ, Thomas S, et al. Measurement of theclinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis.Health Technol Assess 2006;15(10).188NIHR Journals Library